Last Updated:
NameDesignationAppointment DateStatus
Rajan Gunaseelan

Appointed as Director since February 2006

Director10-Feb-2006Current
Ravisubramanian

Appointed as Director since February 2006

Director10-Feb-2006Current
Selvakumar Selvarangan

Appointed as Director since February 2006

Director10-Feb-2006Current
Venkatesh Kadiresan Nadar

Appointed as Director since February 2006

Director10-Feb-2006Current
Premium access

Complete director details

Unlock the complete director and KMP records available for Merit Clinical Research Private Limited.

  • Complete appointment and designation records
  • Current and past company associations
  • Shareholding and remuneration where filed

Verified entity values are shown only after access is granted.

People Timeline

Explore the timeline of key personnel in Merit Clinical Research Private Limited's leadership journey.

Loading...
Contact Details
  • Address 56, Dr. Radhakrishnan Salai Mylapore,, Chennai Tamil Nadu, 600004, India
  • Telephone Upgrade
  • Email Upgrade
  • Pin Code 600004
  • Country India
  • Website -
Frequently Asked Questions
You can contact Merit Clinical Research Private Limited through their registered address at 56, Dr. Radhakrishnan Salai Mylapore,, Chennai Tamil Nadu, 600004, India, or via their website if available. Social media links are also provided where applicable.
The current directors of Merit Clinical Research Private Limited are listed above in the "Current Directors & Signatories" section. You can view their names, designations, and appointment dates.
  • RAVISUBRAMANIAN
  • RAJAN GUNASEELAN
  • VENKATESH KADIRESAN NADAR
  • SELVAKUMAR SELVARANGAN
Past director details are available under the "Past Directors & Signatories" tab. You may need to upgrade your subscription to view detailed information.
Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available